Stockreport

How Early Zugo-cel Data and Lilly Partnership Could Impact CRISPR Therapeutics (CRSP) Investors [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF B-cell lymphoma and autoimmune diseases, and disclosed a new collaboration with Eli Lilly to test zugo-cel alongside pirtobrutinib. By pairing strong initial response [Read more]